Schrödinger Inc., 1540 Broadway, 24th floor, New York, New York 10036, United States.
J Chem Theory Comput. 2022 Apr 12;18(4):2354-2366. doi: 10.1021/acs.jctc.1c00821. Epub 2022 Mar 15.
Transferable high dimensional neural network potentials (HDNNPs) have shown great promise as an avenue to increase the accuracy and domain of applicability of existing atomistic force fields for organic systems relevant to life science. We have previously reported such a potential (Schrödinger-ANI) that has broad coverage of druglike molecules. We extend that work here to cover ionic and zwitterionic druglike molecules expected to be relevant to drug discovery research activities. We report a novel HDNNP architecture, which we call QRNN, that predicts atomic charges and uses these charges as descriptors in an energy model that delivers conformational energies within chemical accuracy when measured against the reference theory it is trained to. Further, we find that delta learning based on a semiempirical level of theory approximately halves the errors. We test the models on torsion energy profiles, relative conformational energies, geometric parameters, and relative tautomer errors.
可转移的高维神经网络势(HDNNPs)在提高与生命科学相关的有机体系中现有原子力场的准确性和适用范围方面显示出巨大的潜力。我们之前报道了一种具有广泛药物样分子覆盖范围的这种潜力(Schrödinger-ANI)。我们在此扩展了这项工作,以涵盖预计与药物发现研究活动相关的离子和两性离子药物样分子。我们报告了一种新的 HDNNP 架构,我们称之为 QRNN,它可以预测原子电荷,并在能量模型中使用这些电荷作为描述符,该模型在与训练它的参考理论进行比较时,可以在化学精度内提供构象能。此外,我们发现基于半经验理论的增量学习可以将误差减少约一半。我们在扭转能谱、相对构象能、几何参数和相对互变异构体误差方面对模型进行了测试。